Vaccine-maker Moderna (MRNA) reports 4Q earnings before markets open Thursday, Feb. 24, 2022. Brad Loncar breaks down expectations for the quarterly report, as well as how the company has performed over the past few years since the start of the COVID-19 pandemic. Consensus calls for Moderna to report EPS of $9.82 on $6.71B in total revenue. The stock is down nearly 50 percent year-to-date and has underperformed the broader market.
Market On Close
23 Feb 2022
SHARE
Market On Close
31 Jan 2023
Market On Close
10 Jan 2023
The Watch List
22 Jan 2023
Market On Close
24 Feb 2023
The Watch List
17 Feb 2023